EXPD(EXPD)
EXPD
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $11.64B | $12.00B | $12.60B |
| Low | $11.50B | $11.75B | $12.59B |
| High | $11.78B | $12.48B | $12.62B |
| EBITDA Avg | $1.31B | $1.35B | $1.42B |
| Low | $1.29B | $1.32B | $1.41B |
| High | $1.32B | $1.40B | $1.42B |
| EBIT Avg | $1.25B | $1.29B | $1.35B |
| Low | $1.24B | $1.26B | $1.35B |
| High | $1.27B | $1.34B | $1.36B |
| Net Income Avg | $895M | $898M | $966M |
| Low | $866M | $820M | $930M |
| High | $966M | $1.00B | $978M |
| EPS Avg | $6.80 | $6.83 | $7.03 |
| Low | $6.36 | $6.02 | $6.82 |
| High | $7.09 | $7.35 | $7.18 |
| Analysts (Rev / EPS) | 9 / 10 | 9 / 10 | 5 / 3 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|---|
| Revenue Avg | $2.84B | $3.03B | $2.98B | $2.88B | $2.83B | $3.08B | $3.05B |
| Low | $2.73B | $2.96B | $2.87B | $2.77B | $2.72B | $2.96B | $2.93B |
| High | $2.85B | $3.12B | $3.15B | $3.05B | $2.99B | $3.26B | $3.22B |
| EBITDA Avg | $319M | $341M | $335M | $324M | $317M | $346M | $343M |
| Low | $306M | $333M | $322M | $311M | $305M | $333M | $329M |
| High | $320M | $350M | $354M | $342M | $336M | $366M | $362M |
| EBIT Avg | $305M | $326M | $320M | $309M | $304M | $331M | $328M |
| Low | $293M | $318M | $308M | $297M | $292M | $318M | $315M |
| High | $306M | $335M | $339M | $327M | $321M | $350M | $346M |
| Net Income Avg | $220M | $241M | $220M | $218M | $216M | $242M | $227M |
| Low | $212M | $224M | $209M | $207M | $205M | $230M | $215M |
| High | $230M | $260M | $236M | $234M | $232M | $260M | $243M |
| EPS Avg | $1.64 | $1.79 | $1.64 | $1.63 | $1.61 | $1.81 | $1.69 |
| Low | $1.58 | $1.67 | $1.56 | $1.54 | $1.53 | $1.72 | $1.61 |
| High | $1.71 | $1.94 | $1.76 | $1.75 | $1.73 | $1.94 | $1.82 |
| Analysts (Rev / EPS) | 5 / 7 | 5 / 7 | 2 / 3 | 2 / 3 | 2 / 2 | 2 / 2 | 2 / 2 |